DEF 14AThe Ballot
AN2 Therapeutics, Inc. files DEF 14A
Filed Apr 26, 2024 · 2y ago · Accession 0000950170-24-049148
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- AN2 Therapeutics, Inc.
- Ticker
- ANTX
- CIK
- 1880438
- Form type
- DEF 14A
- Filing date
- Apr 26, 2024
- Report date
- Jun 19, 2024
- Document
- antx-def14a-2023.htm
- Size
- 3.9 MB